who is not a candidate for glp 1 GLP-1s are one of the most talked-about drugs in medicine right now. Most of the conversation missing the point. The real mechanism isn't weight loss. It's metabolic recalibration, restoring the communication Are GLP1’s For Everyone? Which

A.JayaramanM.MatsudaS.LiuJ.BarrosS.QuerbesW.et al (2021)

Andy Piccolantonio, chief growth officer for the restaurant industry trade group, said the findings present a new challenge ahead for restaurants

Alcohol-based mouthwash dries out the tissues

As of early 2026, multiple Phase 3 trials have reported positive topline results, regulatory submissions have been filed, and the FDA is reviewing orforglipron for an obesity indication with a target action date of April 10, 2026

These nine companies are building on what Ozempic started, betting on pills instead of injections, drugs that spare muscle, and uses well beyond obesity